XML 94 R80.htm IDEA: XBRL DOCUMENT v3.22.4
Note 14 - Parent Company Financial Statements (Unaudited) - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Net loss   $ (107,758) $ (47,147)
Share-based compensation   6,410 3,928
Depreciation   5,535 5,448
Debt related fees and amortization expense   7,363 3,921
Gain on debt extinguishment   (49,386) 1,134
Gain on litigation $ (1,400) (1,400) 0
Prepaid expenses   (1,777) 4,849
Accounts payable   2,183 (5,198)
Accrued interest expense   15,501 14,456
Other liabilities   (10,125) 729
Net cash used in operating activities   (22,866) (20,647)
Capital expenditures   (39,157) (26,652)
Net cash provided by (used in) investing activities   (31,306) (22,894)
Proceeds from the exercise of stock options   206 1,304
Proceeds from issuance of common stock in equity offering   11,987 103,591
Net cash provided by financing activities   53,633 50,704
Net increase in cash, cash equivalents, and restricted cash   (752) 7,159
Cash, cash equivalents, and restricted cash at beginning of period   7,751 592
Cash, cash equivalents, and restricted cash at end of period   6,999 7,751
Income taxes paid   10 7
Fair value of warrants issued to subordinated debt holders   1,939 1,546
Fair value of stock issued to a related party for guarantee fees   2,012 0
Fair value of warrants issued for capital expenditures   0 1,344
Fair value of warrants issued to lender for debt issuance costs   3,158 0
Fair value of stock issued to lender   1,335 0
Issuance of equity to pay off accounts payable   0 893
Parent Company [Member]      
Net loss   (107,758) (47,147)
Share-based compensation   6,410 3,928
Depreciation   29 8
Debt related fees and amortization expense   1,776 0
Subsidiary portion of net losses   91,561 34,400
Gain on debt extinguishment   0 (421)
Gain on litigation   (1,400) 0
Prepaid expenses   111 (38)
Accounts payable   (90) (1,043)
Accrued interest expense   778 998
Other liabilities   (4,625) (902)
Other assets   207 109
Net cash used in operating activities   (13,001) (10,108)
Capital expenditures   (128) 0
Subsidiary advances, net   1,222 (95,105)
Net cash provided by (used in) investing activities   1,094 (95,105)
Proceeds from the exercise of stock options   206 1,304
Proceeds from issuance of common stock in equity offering   11,987 103,591
Net cash provided by financing activities   12,193 104,895
Net increase in cash, cash equivalents, and restricted cash   286 (318)
Cash, cash equivalents, and restricted cash at beginning of period   0 318
Cash, cash equivalents, and restricted cash at end of period   286 0
Income taxes paid   7 7
Fair value of warrants issued to subordinated debt holders   1,939 1,546
Fair value of stock issued to a related party for guarantee fees   2,012 0
Fair value of warrants issued for capital expenditures   0 1,344
Fair value of warrants issued to lender for debt issuance costs   3,158 0
Fair value of stock issued to lender   1,335 0
Issuance of equity to pay off accounts payable   $ 0 $ 893